Ovarian cancer: open trials in Mexico

11 open trials have a site in Mexico. Registry data; only the trial team decides who can take part.

NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Trial Treatment · Phase 3 · NRG Oncology
Instituto Nacional De Cancerologia de Mexico, Mexico City
Registry updated 2026-11-04
NCT07213804
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Scientia Investigacion Clinica S.C., Chihuahua City · Higiea Oncologia, Mexico City · Health Pharma Professional Research S.A. de C.V., Mexico City · INCAN, Mexico City · Unidad Médica Onco-hematológica, Puebla City · Hospital Angeles, Tijuana
Registry updated 2026-11-04
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Medical Care & Research Sa de Cv, Mérida · Centro de Atenciă"N E Investigaciă"N Clă Nica En Oncologă A, Mérida · Cryptex Investigacion Clinica S.A. de C.V., México
Registry updated 2026-10-26
NCT05645536
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
Trial Treatment · Phase 3 · Tolmar Inc.
CIMET Scientific Corporation S. A. P. I. de C. V., Guadalajara · Amiisto Atencion Medica Integral, Investigacion Y Terapia Oncologica S. A. DE C. V., Madero · Atencion Medica Integral E Investigacion en Terapia Oncologica, Mexico City · Unidad de Medicina Especializada SMA, San Juan del Río · FAICIC S de RL de C.V., Veracruz
Registry updated 2026-10-23
NCT06824467
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Centro de Investigación Oncológica Galerías SC (Site 1720), Aguascalientes · Cryptex Investigación Clínica S.A. de C.V. (Site 1715), Cuauhtémoc · CIO - Centro de Inmuno-Oncología de Occidente (Site 1719), Guadalajara · Higiea Oncologia (Site 1713), Mexico City · COI Centro Oncologico Internacional S.A.P.I. de C.V. (Site 1717), Mexico City · Servicios de Oncología Médica Integral - Monterrey (Site 1712), Monterrey · I CAN ONCOLOGY CENTER S.A. DE C.V. (Site 1716), Monterrey · Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" (Site 1711), Monterrey · Centro de Investigacion Clinica de Oaxaca (Site 1714), Oaxaca City
Registry updated 2026-10-13
NCT04575935
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Trial Treatment · Phase 3 · M.D. Anderson Cancer Center
Instituto Nacional de Cancerología (Mexico), Tlalpan
Registry updated 2026-09-14
NCT07539844
Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries
Research · AbbVie
Mexico - Generic Institution /ID# 281928, Mexico City · Mexico - Generic Institution /ID# 281930, Mexico City · Mexico - Generic Institution /ID# 281927, Mexico City
Registry updated 2026-09-14
NCT07771400
Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients
Research · Latin American Cooperative Oncology Group
Hospital Ángeles Pedregal, Mexico City · INCan - Instituto Nacional de Cancerología, Mexico City · TecSalud (Tecnológico de Monterrey), Nuevo León
Registry updated 2026-08-25
NCT04294927
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Trial Treatment · University Medical Center Nijmegen
Instituto Nacional de Cancerologia, Mexico City
Registry updated 2026-04-06
NCT06883409
Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer
Trial Treatment · Instituto Nacional de Cancerologia de Mexico
Instituto Nacional de Cancerologia, México
Registry updated 2025-03-26
NCT03275194
HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
Trial Treatment · Phase 2 · Instituto Nacional de Cancerologia de Mexico
National Cancer Institute of Mexico, Mexico City
Registry updated 2023-04-28

All Ovarian cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error